While Pulmonary Fibrosis (PF) is considered rare in Australia, disease burden is significant and prevalence is increasing year by year. Detection and diagnosis can be complex, particularly as signs and symptoms of PF mirror numerous other respiratory and cardiac conditions. Early and accurate diagnosis and referral is a critical step in optimising patient outcomes in this progressive disease. While there is no cure for PF, there are various evidence-based treatment options and management strategies to help slow or stop progression and manage symptoms.
To mark Pulmonary Fibrosis Awareness Month this September, Lung Foundation Australia is proud to present this virtual learning event focussed on earlier detection, diagnosis and management of PF in primary care.
Ask our expert panel your questions at registration, or live during the Q&A session.
Learning outcomes:
- Outline the disease burden of Pulmonary Fibrosis in Australia.
- Discuss evidence-based practice to support earlier detection and diagnosis of Pulmonary Fibrosis.
- Identify support pathways and resources for best-practice management of Pulmonary Fibrosis in Australia.
Speakers
- Dr John Mackintosh
Respiratory and Lung Transplant Physician, The Prince Charles Hospital - Sarah Watson
Interstitial Lung Disease Clinical Nurse, The Prince Charles Hospital - Angelica Maye Bariuan
Respiratory Clinical Nurse Consultant, Western Sydney Local Health District
This virtual learning event is proudly supported by:
Was this page helpful?
Good job! Please give your positive feedback
How could we improve this post? Please Help us.
